US President Donald Trump’s restriction on US entities investing in some Chinese stocks has started to show its ripple effects in the region. Goldman Sachs Group Inc., Morgan Stanley and JPMorgan Chase & Co. said they will delist some 500 structured products in Hong Kong, including warrants and callable bull/bear contracts (CBBCs) on Hong Kong’s benchmark Hang Seng Index, and…
To access this content, please click back to the home screen, then click “Menu” (bars in top left bars) and then “Login”.
To enquire for a free trial, please start here.
Need more help? Click here or email [email protected].
To enquire for a free trial, please start here.
Need more help? Click here or email [email protected].
Subscriber Only Content
This article is available on a corporate subscription with Asian Private Banker. Please login or subscribe to view this content.
Need help? Please see our FAQ Guide or email [email protected]
Have a confidential tip? Get in touch [email protected]
